Mostrando 6 resultados de: 6
Filtros aplicados
Characterization of the primary structure of the recombinant human interleukin-2
ArticleAbstract:Palabras claves:Autores:Araña M.J., Besada-Pérez V., Castellanos L.R., López P., Mata H., Mateo de Acosta C., Richardson M., Vivian Morera CórdovaFuentes:scopusBiochemical characterization and experimental tumor targeting properties of an anti-CEA antibody fragment produced in E. Coli
ArticleAbstract: Aim. The authors study biochemical and biological properties of bacterially produced scFv antibody fPalabras claves:Carcinoembryonic antigen, ESCHERICHIA coli, Immunoglobulin fragmentsAutores:Ayala M., Bell H., Canaán L., Gavilondo J.V., Martínez Y.R., Miranda M., Musacchio Lasa A., Oliva J.P., Pérez Sánchez L., Pimentel G., Ravelo R., Sánchez I., Vivian Morera CórdovaFuentes:scopusAltered peptide ligand derived from HSP60 and pharmaceutical compositions
OtherAbstract: The present invention is related with peptides of human heat shock protein of 60 kDa (abbreviated hHPalabras claves:Autores:Vivian Morera CórdovaFuentes:googleMolecular characterization of recombinant human interferon alpha-2b produced in Cuba
ArticleAbstract: The recombinant human interferon α 2b (IFN-γ(2b)) produced by Cuban technology is obtained from EschPalabras claves:IFN, Molecular characterization, Recombinant human interferon alfa 2bAutores:Beldarrain A., Besada-Pérez V., Betancourt L., Brito R., Curras T., Eugenio Hardy, Ferrero J., Gil M., González L.J., Herrera L., Huerta V., Martinez E., Moya G., Pujols V., Sanchez J.C., Santana-Milián H., Sosa R., Vivian Morera CórdovaFuentes:googlescopusProtective immune response against Neisseria meningitidis serogroup B after immunization with peptides mimicking a capsular polysaccharide epitope
ArticleAbstract:Palabras claves:Autores:Brown E., Caballero E., Carmenate T., Chinea G., Cobas K., Coizeau E., Cruz Y., Garay H.E., González S., Guillén-Nieto G.E., Martín A., Menéndez T., Noda J., Reyes O., Santiago Nelson Vispo, Soria Y., Vivian Morera Córdova, Yero D.Fuentes:scopusStudy of various presentation forms for a peptide mimetic of Neisseria meningitidis serogroup B capsular polysaccharide
ArticleAbstract: The formulation of a broadly protective vaccine to prevent the serogroup B Neisseria meningitidis (MPalabras claves:Autores:Alberício F., Coizeau E., Cruz-Leal Y., Garay H.E., Guillén-Nieto G.E., Menéndez T., Noda J., Reyes O., Vivian Morera CórdovaFuentes:scopus